Innoviva, Inc. - 31 Mar 2022 Form 4 Insider Report for Armata Pharmaceuticals, Inc. (ARMP)

Role
Director, 10%+ Owner
Signature
INNOVIVA, INC., by /s/ Pavel Raifeld, Chief Executive Officer
Issuer symbol
ARMP
Transactions as of
31 Mar 2022
Net transactions value
+$26,926,040
Form type
4
Filing time
01 Apr 2022, 16:52:45 UTC
Previous filing
23 Feb 2022
Next filing
13 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARMP Common Stock Purchase $26,926,040 +5,385,208 +49% $5.00 16,365,969 31 Mar 2022 See footnotes F1, F2
holding ARMP Common Stock 8,710,800 31 Mar 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARMP Warrants to Purchase Common Stock Purchase $0 0 0% $5.00 2,692,604 31 Mar 2022 Common Stock 2,692,604 $5.00 See footnotes F1, F2
holding ARMP Warrants to Purchase Common Stock 1,807,396 31 Mar 2022 Common Stock $5.00 See footnote F3
holding ARMP Warrants to Purchase Common Stock 6,153,847 31 Mar 2022 Common Stock $3.25 See footnote F4
holding ARMP Warrants to Purchase Common Stock 8,710,800 31 Mar 2022 Common Stock $2.87 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 See Exhibit 99.1
F2 See Exhibit 99.1
F3 See Exhibit 99.1
F4 See Exhibit 99.1
F5 See Exhibit 99.1